Kinji Ohno

Overview

Best Publications

• Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease

  Satoru Hasegawa;Sae Goto;Hirokazu Tsuji;Tatsuya Okuno

  535
  Citations

• Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence.

  Shin-ichiro Ikebe;Masashi Tanaka;Kinji Ohno;Wataru Sato

  470
  Citations

• CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study

  Manabu Funayama;Kenji Ohe;Kenji Ohe;Taku Amo;Norihiko Furuya

  348
  Citations

• Mutation of the acetylcholine receptor α subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity

  Steven M. Sine;Kinji Ohno;Cecilia Bouzat;Anthony Auerbach

  315
  Citations

• Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans

  Kinji Ohno;Akira Tsujino;Joan M. Brengman;C. Michel Harper

  309
  Citations

• Human branch point consensus sequence is yUnAy

  Kaiping Gao;Akio Masuda;Tohru Matsuura;Kinji Ohno

  307
  Citations

• Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit.

  Kinji Ohno;David O. Hutchinson;Margherita Milone;Joan M. Brengman

  305
  Citations

• Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients

  Duygu Selcen;Kinji Ohno;Andrew G. Engel

  304
  Citations

• Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme

  Kinji Ohno;Joan Brengman;Akira Tsujino;Andrew G. Engel

  281
  Citations

• Congenital Myasthenic Syndrome Caused by Decreased Agonist Binding Affinity Due to a Mutation in the Acetylcholine Receptor ε Subunit

  Kinji Ohno;Hai Long Wang;Margherita Milone;Nina Bren

  271
  Citations

• Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome.

  Kinji Ohno;Andrew G. Engel;Xin Ming Shen;Duygu Selcen

  271
  Citations

• Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease.

  Yuan Fu;Mikako Ito;Yasunori Fujita;Masafumi Ito

  258
  Citations

• Meta‐Analysis of Gut Dysbiosis in Parkinson's Disease

  Hiroshi Nishiwaki;Mikako Ito;Tomohiro Ishida;Tomonari Hamaguchi

  256
  Citations

• New Mutations in Acetylcholine Receptor Subunit Genes Reveal Heterogeneity in the Slow-Channel Congenital Myasthenic Syndrome

  Andrew G. Engel;Kinji Ohno;Margherita Milone;Hai Long Wang

  251
  Citations

• Peroxisome targeting signal of rat liver acyl-coenzyme A oxidase resides at the carboxy terminus.

  S Miyazawa;T Osumi;T Hashimoto;K Ohno

  246
  Citations

• Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions

  Shinsuke Ishigaki;Akio Masuda;Yusuke Fujioka;Yohei Iguchi

  244
  Citations

• Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis

  Takayuki Ozawa;Masashi Tanaka;Shin-ichiro Ikebe;Kinji Ohno

  223
  Citations

• Myasthenic syndrome caused by mutation of the SCN4A sodium channel

  Akira Tsujino;Chantal Maertens;Kinji Ohno;Xin-Ming Shen

  214
  Citations

• Multiple mitochondrial DNA deletions exist in cardiomyocytes of patients with hypertrophic or dilated cardiomyopathy.

  Takayuki Ozawa;Masashi Tanaka;Satoru Sugiyama;Kazuki Hattori

  210
  Citations

• Acetylcholine receptor M3 domain: stereochemical and volume contributions to channel gating.

  Hai Long Wang;Margherita Milone;Kinji Ohno;Xing Ming Shen

  139
  Citations